蒲公英 - 制药技术的传播者 GMP理论的实践者

搜索
查看: 944|回复: 2
收起左侧

[行业动态] EMA: More GMP/GDP Inspections performed

[复制链接]
药士
发表于 2018-8-17 18:23:33 | 显示全部楼层 |阅读模式

欢迎您注册蒲公英

您需要 登录 才可以下载或查看,没有帐号?立即注册

x
15.08.2018

EMA: More GMP/GDP Inspections performed
According to the 2017 Annual Report of the European Medicines Agency EMA, which was recently published, the number of GMP and GDP inspections performed by EEA authorities increased again.
Last year, 2.493 sites were inspected worldwide for GMP. Out of these, 17 sites failed and received GMP non-compliance statements. In 2016, 2.293 GMP inspections were performed leading to 25 non-compliance statements.
These GMP Non-Compliance Statements can lead to a:
  • a supply stop
  • removal of a manufacturing site from the dossier
  • removal/ replacement of a manufacturing site during the assessment procedure (prior approval)
  • withdraw of an application for marketing authorisation
  • recall of medicinal products
Most of the third country inspections were performed in India. Although the MRA with the USA was already on its way, the United States are on second place:

Country
GMP Certificates
GMP Non-Compliance Statements
China
39
1
India
119
7
United States
106
0
ROW*
97
2
Figure: Inspection outcomes following EEA inspections performed in third countries in 2017 (with data extracted from EudraGMDP on 9th January). Source: EMA Annual Report

Also a high number of GDP inspections was performed in 2017; EEA authorities issued 1.928 GDP certificates and 6 GDP non-compliance reports.

*ROW includes the following countries: Argentina, Bangladesh, Brazil, Canada, Chile, Egypt, Iran, Japan, Jordan, Republic of Korea, Lebanon, The former Yugoslav Republic of Macedonia, Malaysia, Mexico, Monaco, Montenegro, Morocco, Oman, Pakistan, Russia, San Marino, Serbia, Singapore, South Africa, Taiwan, Thailand, Turkey, Ukraine, United Arab Emirates, Vietnam.
EMA's report also gives an overview on updates to the various Mutual recognition agreements (MRAs), other international co-operation and harmonisation activities and GMP and GDP Guidance.

回复

使用道具 举报

药士
 楼主| 发表于 2018-8-17 18:26:05 | 显示全部楼层
整体GMP检查数量有增,但是针对于中国的检查却又约30%的减少。
[GMP相关] EMA GMP/GDP IWG年度报告(2018-07)
回复

使用道具 举报

药徒
发表于 2018-8-18 08:19:22 | 显示全部楼层
非常感谢分享,谢谢
回复

使用道具 举报

您需要登录后才可以回帖 登录 | 立即注册

本版积分规则

×发帖声明
1、本站为技术交流论坛,发帖的内容具有互动属性。您在本站发布的内容:
①在无人回复的情况下,可以通过自助删帖功能随时删除(自助删帖功能关闭期间,可以联系管理员微信:8542508 处理。)
②在有人回复和讨论的情况下,主题帖和回复内容已构成一个不可分割的整体,您将不能直接删除该帖。
2、禁止发布任何涉政、涉黄赌毒及其他违反国家相关法律、法规、及本站版规的内容,详情请参阅《蒲公英论坛总版规》。
3、您在本站发表、转载的任何作品仅代表您个人观点,不代表本站观点。不要盗用有版权要求的作品,转贴请注明来源,否则文责自负。
4、请认真阅读上述条款,您发帖即代表接受上述条款。

QQ|手机版|蒲公英|ouryao|蒲公英 ( (京)-非经营性-2014-0058 京ICP证150354号 京ICP备14042168号-1 )

GMT+8, 2024-3-29 00:47

Powered by Discuz! X3.4运维单位:苏州豚鼠科技有限公司

Copyright © 2001-2020, Tencent Cloud.

声明:蒲公英网站所涉及的原创文章、文字内容、视频图片及首发资料,版权归作者及蒲公英网站所有,转载要在显著位置标明来源“蒲公英”;禁止任何形式的商业用途。违反上述声明的,本站及作者将追究法律责任。
快速回复 返回顶部 返回列表